Mackenzie Financial’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.6M Buy
137,195
+77,839
+131% +$16.2M 0.03% 333
2026
Q1
$12.5M Buy
59,356
+20,436
+53% +$4.4M 0.02% 486
2025
Q4
$8.05M Buy
38,920
+4,271
+12% +$804K 0.01% 545
2025
Q3
$5.44M Buy
34,649
+5,626
+19% +$869K 0.01% 622
2025
Q2
$4.88M Buy
29,023
+2,616
+10% +$388K 0.01% 605
2025
Q1
$3.64M Sell
26,407
-63,865
-71% -$8.14M 0.01% 647
2024
Q4
$10.7M Sell
90,272
-77,001
-46% -$8.99M 0.01% 456
2024
Q3
$18.5M Sell
167,273
-76,751
-31% -$8.02M 0.03% 357
2024
Q2
$24M Sell
244,024
-39,299
-14% -$4M 0.04% 302
2024
Q1
$31.7M Sell
283,323
-15,309
-5% -$1.65M 0.05% 274
2023
Q4
$30.1M Sell
298,632
-27,372
-8% -$2.72M 0.05% 275
2023
Q3
$28.3M Buy
326,004
+24,979
+8% +$2.26M 0.05% 266
2023
Q2
$28.5M Buy
301,025
+63,088
+27% +$5.33M 0.04% 276
2023
Q1
$18M Buy
237,937
+72,238
+44% +$5.45M 0.03% 350
2022
Q4
$12.7M Buy
165,699
+130,906
+376% +$9.95M 0.02% 369
2022
Q3
$2.32M Sell
34,793
-38,355
-52% -$2.43M ﹤0.01% 660
2022
Q2
$3.82M Sell
73,148
-7,278
-9% -$414K 0.01% 584
2022
Q1
$4.56M Sell
80,426
-5,720
-7% -$306K 0.01% 594
2021
Q4
$4.44M Sell
86,146
-29,064
-25% -$1.43M 0.01% 604
2021
Q3
$5.7M Buy
115,210
+14,678
+15% +$796K 0.01% 549
2021
Q2
$5.74M Sell
100,532
-28,379
-22% -$1.66M 0.01% 536
2021
Q1
$7.83M Buy
128,911
+69,397
+117% +$3.83M 0.01% 458
2020
Q4
$3.19M Buy
59,514
+11,503
+24% +$597K 0.01% 521
2020
Q3
$2.25M Buy
48,011
+2,768
+6% +$142K 0.01% 535
2020
Q2
$2.36M Sell
45,243
-32,731
-42% -$1.69M 0.01% 520
2020
Q1
$3.74M Sell
77,974
-90,519
-54% -$4.7M 0.01% 380
2019
Q4
$8.52M Sell
168,493
-67,366
-29% -$3.48M 0.02% 352
2019
Q3
$11.1M Buy
235,859
+122,666
+108% +$5.6M 0.03% 318
2019
Q2
$5.33M Buy
113,193
+6,398
+6% +$295K 0.01% 423
2019
Q1
$5.14M Sell
106,795
-24,766
-19% -$1.24M 0.01% 512
2018
Q4
$5.87M Sell
131,561
-47,055
-26% -$2.45M 0.02% 472
2018
Q3
$9.64M Buy
178,616
+59,221
+50% +$3.03M 0.02% 340
2018
Q2
$5.83M Sell
119,395
-106,436
-47% -$6.04M 0.01% 418
2018
Q1
$14.2M Sell
225,831
-13,325
-6% -$914K 0.04% 279
2017
Q4
$14.7M Sell
239,156
-14,205
-6% -$878K 0.04% 299
2017
Q3
$17M Buy
253,361
+11,430
+5% +$808K 0.09% 201
2017
Q2
$18.9M Sell
241,931
-33,753
-12% -$2.55M 0.1% 186
2017
Q1
$22.5M Buy
275,684
+48,198
+21% +$3.79M 0.13% 168
2016
Q4
$16.4M Buy
227,486
+73,229
+47% +$5.29M 0.1% 181
2016
Q3
$12M Sell
154,257
-5,770
-4% -$466K 0.07% 199
2016
Q2
$12.5M Buy
160,027
+138,858
+656% +$11.1M 0.07% 229
2016
Q1
$1.74M Buy
21,169
+17,007
+409% +$1.38M 0.02% 381
2015
Q4
$372K Buy
4,162
+389
+10% +$33K ﹤0.01% 717
2015
Q3
$290K Sell
3,773
-8,598
-70% -$719K ﹤0.01% 739
2015
Q2
$1.03M Buy
12,371
+9,696
+362% +$856K 0.01% 550
2015
Q1
$241K Sell
2,675
-1,634
-38% -$141K ﹤0.01% 752
2014
Q4
$348K Buy
+4,309
New +$340K ﹤0.01% 677

Other funds holding CAH

Mackenzie Financial's CAH Position: Q2 2026 in Review

Mackenzie Financial increased its Cardinal Health (CAH) stake by 131% in Q2 2026, buying an estimated $16.2M and bringing the position to 137,195 shares worth $32.6M. The position accounts for 0.03% of the portfolio, ranked #333.

Mackenzie Financial first reported a position in CAH in Q4 2014 and has held it in 47 quarters since. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Mackenzie Financial held 137,195 shares of Cardinal Health worth $32.6M as of Q2 2026.
  • Mackenzie Financial bought 77,839 Cardinal Health shares in Q2 2026, an estimated $16.2M.
  • Cardinal Health made up 0.03% of Mackenzie Financial's portfolio in Q2 2026, its #333 holding.
  • Mackenzie Financial first reported a position in Cardinal Health in Q4 2014 and has held it in 47 quarters since.
  • 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.